U.S. Life Sciences Stock News

If you are wondering whether Southwest Gas Holdings at around US$88 per share offers good value today, you are not alone; many investors are trying to work out what a fair price looks like. The stock has returned 0.7% over the last week, 7.6% over the past month, 10.0% year to date, 21.3% over one year, 62.5% over three years and 51.5% over five years, which naturally raises questions about how its current price lines up with its fundamentals. Recent news flow around regulated utilities, gas...

United Natural Foods (NYSE:UNFI) hosted its 2026 Spring and Summer Selling Show, bringing together thousands of retailers and suppliers. The company unveiled nearly 50 new private label products across categories at the event. Key themes included healthier food offerings, private brand development, and growing interest in gut health. For you as an investor, this matters because UNFI sits at the center of the natural, specialty, and conventional grocery supply chain, connecting brands with...

Xylem (NYSE:XYL) has authorized a new share repurchase program of up to $1.5b. The program allows the company to buy back shares opportunistically over time. The announcement comes with Xylem shares recently trading around $129.56. Xylem, trading on the NYSE under the ticker XYL, is moving ahead with a sizeable $1.5b buyback plan at a share price of about $129.56. Over the past 3 years, the stock has returned 29.3%, and 37.1% over 5 years, which gives context for how management is choosing...

Xenon Pharmaceuticals (XENE) has put fresh numbers on the table for FY 2025, with first half revenue at US$7.5 million and a basic EPS loss of US$1.90, alongside a trailing twelve month EPS loss of US$4.36. The company has seen revenue move from US$0 in both halves of 2024 to US$7.5 million in the latest half. Basic EPS losses widened from US$1.36 and US$1.64 in the first and second halves of 2024 to US$1.90 most recently and a trailing twelve month net loss of US$345.91 million, keeping...

American Healthcare REIT (AHR) has wrapped up FY 2025 with Q4 revenue of US$604.1 million and basic EPS of US$0.06, rounding out a trailing twelve month picture that shows total revenue of about US$2.3 billion and basic EPS of US$0.42. Over the past few quarters the REIT has seen revenue move from US$540.2 million in Q4 2024 to US$604.1 million in Q4 2025, while quarterly EPS shifted from a loss of US$0.20 per share to a profit of US$0.06 per share. This sets up a year where investors will be...

GoodRx Holdings (GDRX) is back in focus after launching its Employer Direct platform to help companies reduce high-impact brand drug costs, alongside 2025 earnings, fresh 2026 guidance, and a cluster of analyst rating changes. See our latest analysis for GoodRx Holdings. GoodRx’s recent earnings update, 2026 revenue guidance and the Employer Direct launch have been followed by a sharp reset in sentiment, with a 7 day share price return of 24.29% decline and a 1 year total shareholder return...

Burford Capital (NYSE:BUR) rounded out FY 2025 with Q4 revenue of US$33.4 million and a basic EPS loss of US$0.17, as quarterly earnings swung back into the red despite a profitable first half. The company has seen quarterly revenue move from US$244.9 million and EPS of US$0.62 in Q3 2024 to US$178.0 million and EPS of US$0.40 in Q2 2025, and then to US$64.7 million with an EPS loss of US$0.09 in Q3 2025 before landing at the latest Q4 figures. This sets up a results season in which investors...

If you are wondering whether Thermon Group Holdings is still attractively priced or already reflecting most of its potential, you are in the right place for a valuation-focused look at the stock. The share price, last closing at US$50.78, comes with a mixed return profile, with a 0.5% decline over 7 days, a 16.9% gain over 30 days, 34.9% year to date, 72.1% over 1 year, 84.6% over 3 years and 136.7% over 5 years. Recent price action sits alongside ongoing news flow around Thermon Group...

D-Market Elektronik Hizmetler ve Ticaret (NasdaqGS:HEPS) has wrapped up FY 2025 with Q4 revenue of approximately ₺30.3b and a net loss of about ₺3.2b, capping a year in which trailing twelve month revenue reached roughly ₺84.7b alongside a total net loss of around ₺5.7b. The company reported quarterly revenue increasing from about ₺20.4b in Q4 2024 to ₺30.3b in Q4 2025, while quarterly net losses widened from roughly ₺724m to about ₺3.2b over the same period. EPS on a trailing twelve month...

MannKind (MNKD) has wrapped up FY 2025 with fourth quarter revenue of US$112 million and a basic EPS loss of US$0.05, setting a clear focal point for investors watching how its income statement is evolving. Over recent periods the company has seen revenue move from US$70 million in Q3 2024 to US$82 million in Q3 2025, while quarterly EPS has ranged from US$0.04 in Q1 2025 to a small profit of US$0.03 in Q3 2025 before this latest loss. This puts the spotlight firmly on how durable its margins...

Alexander & Baldwin (ALEX) has wrapped up FY 2025 with fourth quarter revenue of US$43.8 million and basic EPS of US$0.05, alongside trailing twelve month revenue of US$206.7 million and EPS of US$0.89. Over the last six quarters, the company has seen quarterly revenue move from US$63.2 million in Q4 2024 to US$56.8 million in Q1 2025 and down to US$43.8 million in Q4 2025, while quarterly EPS moved from US$0.18 to US$0.29 and then US$0.05. This sets up a mixed backdrop for a stock trading at...

C4 Therapeutics (CCCC) just posted its FY 2025 Q4 numbers, with revenue of US$11.0 million and a quarterly loss translating to basic EPS of US$0.18, set against a trailing twelve month loss of US$105.0 million and EPS of US$1.27 on revenue of US$35.9 million. Over recent quarters, the company has seen revenue move between US$5.2 million and US$15.4 million, while quarterly EPS has ranged from US$0.35 to US$0.49 and quarterly losses from US$24.7 million to US$34.6 million. The key question for...

Golden Entertainment (GDEN) has wrapped up FY 2025 with Q4 revenue of US$155.6 million and a basic EPS loss of US$0.33, alongside net income excluding extra items of a US$8.5 million loss. Over recent periods, the company has seen quarterly revenue move between US$154.8 million and US$164.2 million, while EPS has swung from a profit of US$0.18 in Q3 2024 to a loss of US$0.33 in Q4 2025. This leaves investors watching how quickly margins can stabilize from here. See our full analysis for...

Latest Earnings Snapshot Medical Properties Trust (MPW) has wrapped up FY 2025 with fourth quarter revenue of US$294.5 million, basic EPS of US$0.03, and Funds From Operations of US$115.9 million, giving investors a cleaner read on cash based performance for a healthcare REIT. The company has seen revenue move from US$247.5 million in Q3 2024 to US$234.8 million in Q4 2024 and then to US$294.5 million in Q4 2025. Basic EPS shifted from a loss of US$0.69 in Q4 2024 to a loss of US$0.20 in Q1...

A Kinsale Capital Group (NYSE:KNSL) board director recently sold shares, drawing fresh attention to insider activity at the company. Management has flagged moderating premium growth and increasing competition in its core markets. Together, these updates point to a changing operating backdrop that investors are now reassessing. Kinsale Capital Group, trading at $389.67 as of the last close, comes into this news with a mixed recent record. The stock is up 4.4% over the past week, flat over...

NetApp (NTAP) has put another solid quarter on the board, with Q3 2026 revenue of US$1.7 billion, basic EPS of US$1.69 and trailing twelve month EPS of US$6.08 helping frame how the latest print fits into its recent performance. The company has seen revenue move from US$1.66 billion in Q2 2025 to US$1.71 billion in Q3 2026, while quarterly basic EPS has ranged between US$1.16 and US$1.69 over that period. This sets up a story where a stable top line and consistent earnings keep margins firmly...

Neptune Insurance Holdings (NP) closed FY 2025 with Q4 revenue of US$43.8 million and basic EPS of US$0.03, set against trailing 12 month revenue of US$159.6 million and a basic EPS loss of US$0.26. The company has seen quarterly revenue move from US$31.5 million in Q4 2024 to US$43.8 million in Q4 2025. Basic EPS has ranged from a loss of US$0.21 in Q1 2025 to US$0.06 in the year earlier quarter, leaving investors weighing solid top line progress against margins that are still under...

Diana Shipping (NYSE:DSX) has just wrapped up FY 2025 with fourth quarter revenue of US$52.1 million and basic EPS of US$0.02, rounding out a year where trailing twelve month revenue came in at US$213.5 million and EPS at US$0.11. Over recent periods, the company has seen quarterly revenue move between US$51.9 million and US$54.9 million, while basic EPS ranged from about US$0.01 to US$0.07. During the same timeframe, trailing twelve month EPS rose from US$0.06 to US$0.11 as revenue shifted...

D-Wave Quantum (QBTS) has wrapped up FY 2025 with Q4 revenue of US$2.8 million, a basic EPS loss of US$0.12, and a net loss of US$42.3 million. This sets the tone for a year in which the trailing twelve months show US$24.6 million in revenue, a basic EPS loss of US$1.11, and a net loss of US$355.1 million. Over recent quarters, the company has reported quarterly revenue between US$1.9 million and US$15.0 million, while basic EPS has ranged from a loss of US$0.02 to a loss of US$0.55. These...

If you are wondering whether Bio-Rad Laboratories is offering good value at around US$278.44 per share, this article walks through what the current price might be implying about the business. The stock has had a mixed run, with a 2.6% gain over the last 7 days, a 7.1% decline over 30 days, an 8.8% decline year to date, a 5.0% return over 1 year, a 44.6% decline over 3 years, and a 51.0% decline over 5 years. These ups and downs have kept valuation in focus for many investors, especially as...

Dean Kamen has resigned from BETA Technologies’ (NYSE:BETA) Board of Directors following questions about his past associations. Kamen stepped down to avoid potential distractions for the company as scrutiny of his previous dealings with Jeffrey Epstein increased. The resignation draws attention to BETA Technologies’ board composition and broader governance practices at a time when investors are closely watching leadership and oversight. BETA Technologies, traded as NYSE:BETA, focuses on...

Vipshop Holdings (NYSE:VIPS) closed out FY 2025 with fourth quarter revenue of C¥32.5b and basic EPS of C¥5.29, while trailing 12 month revenue stood at C¥105.9b and EPS at C¥14.47. Over the last six reported quarters, the company has seen quarterly revenue range from C¥20.7b to C¥33.2b alongside basic EPS between C¥2.00 and C¥5.29. This gives you a clear view of how top line scale and per share profitability have moved together into this latest print. Taken together with a net margin last...

Intapp (NasdaqGS:INTA) has launched Celeste, a purpose-built agentic AI platform focused on regulated professional services. The company also announced new partnerships with Anthropic to integrate Claude and with Harvey to embed Intapp Walls for ethical compliance in enterprise AI deployments. These moves aim to address compliance-heavy workflows and data governance needs for firms in legal, accounting, and investment banking. For investors watching enterprise software, Intapp sits at the...

RAPT Therapeutics (RAPT) has drawn fresh attention after a sharp move in its share performance over the past 3 months. This has prompted investors to reassess the clinical stage biotech’s risk and reward profile. See our latest analysis for RAPT Therapeutics. At a share price of US$57.96, RAPT Therapeutics has shifted sharply over the past year, with a very large 1 year total shareholder return and a long term total shareholder return that remains negative. This suggests that recent momentum...